<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01224743</url>
  </required_header>
  <id_info>
    <org_study_id>Griffin Hospital IRB #2004-22</org_study_id>
    <nct_id>NCT01224743</nct_id>
  </id_info>
  <brief_title>Effect of Fruit and Vegetable Concentrates on Endothelial Function in Persons With Metabolic Syndrome</brief_title>
  <official_title>Effect of Fruit and Vegetable Concentrates on Endothelial Function in Persons With Metabolic Syndrome: A Randomized, Controlled, Crossover Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Griffin Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>NSA, LLC</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Griffin Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dehydrated fruit and vegetable concentrates provide an accessible form of phytonutrient
      supplementation that may offer cardioprotective effects. This study assessed the effects of
      encapsulated fruit and vegetable juice powder concentrates on endothelial function and
      cardiac risk markers in subjects in a randomized, double blind, placebo controlled crossover
      clinical trial with three treatment arms.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2004</start_date>
  <completion_date type="Actual">March 2008</completion_date>
  <primary_completion_date type="Actual">March 2008</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endothelial Function</measure>
    <time_frame>8-weeks</time_frame>
    <description>Endothelial function as flow-mediated dilatation (FMD)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>8-weeks</time_frame>
    <description>Measured on a calibrated scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lipid panel</measure>
    <time_frame>8-weeks</time_frame>
    <description>Total cholesterol, TG, HDL, LDL, ratio</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin</measure>
    <time_frame>8-weeks</time_frame>
    <description>Serum insulin</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">64</enrollment>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo capsules are provided by the study sponsor and are identical in appearance to active treatments to ensure blinding.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Blend 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Blend 2 - combination of Juice Plus+® Orchard (Fruit) and Garden (Vegetable) blends</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Blend 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Blend 1 - combination of Juice Plus+® Orchard (Fruit), Garden (Vegetable), and Vineyard (Berry) blends</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Blend 1</intervention_name>
    <description>Blend 1 consists of a combination of Juice Plus+® Orchard (Fruit), Garden (Vegetable), and Vineyard (Berry) blends</description>
    <arm_group_label>Blend 1</arm_group_label>
    <other_name>Juice Plus+® Orchard, Garden, Vineyard</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Blend 2</intervention_name>
    <description>Blend 2 consists of a combination of Juice Plus+® Orchard (Fruit) and Garden (Vegetable) blends</description>
    <arm_group_label>Blend 2</arm_group_label>
    <other_name>Juice Plus+® Orchard, Garden</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo capsules are provided by the study sponsor and are identical in appearance to active treatments to ensure blinding.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  metabolic syndrome defined by AHA/NHLBI criteria

          -  nonsmoker

          -  not taking any other vitamins or dietary supplements

          -  able to have blood pressure measured bilaterally at the brachial artery

        Exclusion Criteria:

          -  any unstable medical condition that would limit the ability to participate fully in
             the trial

          -  rheumatologic disease requiring regular use of NSAIDs

          -  preexisting cardiovascular disease

          -  diagnosed eating disorder

          -  inability to complete endothelial function assessment.

          -  use of insulin, glucose sensitizing medication, vasoactive medications (including
             glucocorticoids, antineoplastic agents, psychoactive agents, or bronchodilators),
             nutriceuticals, fiber supplements, and tobacco.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David L Katz, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale-Griffin Prevention Research Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Griffin Hospital</name>
      <address>
        <city>Derby</city>
        <state>Connecticut</state>
        <zip>06418</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 14, 2010</study_first_submitted>
  <study_first_submitted_qc>October 19, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2010</study_first_posted>
  <last_update_submitted>October 19, 2010</last_update_submitted>
  <last_update_submitted_qc>October 19, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 20, 2010</last_update_posted>
  <responsible_party>
    <name_title>David L. Katz, MD, MPH / Director</name_title>
    <organization>Yale-Griffin Prevention Research Center</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

